Filings with the SEC since Feb 23, 2021
1,001 filings, 7 in the last 30 days
Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)
All 30 events
- Nov 3, 2026Officer CFO change (the “Company”) announced that the Board of Directors of the Company unanimously elected Cecile Guegan to serve as Chief Financial Officer, Executive Vice President of the Company, effective November 1, 2026 (the “Effective Date”).
- Nov 3, 20268-K Quarterly results 8-K item 2.02
- Nov 3, 202610-Q Quarterly report (10-Q) period ended Sep 27, 2026
- Aug 12, 2026Buy BOURLA ALBERT (Chairman & CEO) bought $1.0M open-market purchase on Aug 12, 2026
- Aug 12, 2026Cluster buy Cluster buy: 3 insiders bought $3.0M 2026-08-05 to 2026-08-12: BOURLA ALBERT, BLAYLOCK RONALD E, Buckley Mortimer J
- Aug 5, 2026Buy Buckley Mortimer J (Director) bought $960K open-market purchase on Aug 5, 2026
- Aug 5, 2026Buy BLAYLOCK RONALD E (Director) bought $999K open-market purchase on Aug 5, 2026
- Aug 4, 20268-K Quarterly results 8-K item 2.02
- Aug 4, 202610-Q Quarterly report (10-Q) period ended Jun 28, 2026
- Jun 18, 2026Officer CFO change (the “Company”) that he will step down from his current position as Chief Financial Officer effective August 15, 2026 for a professional opportunity outside of the pharmaceutical industry in consumer goods, and that his departure is not related to the Company’s financial or operating results or to any disagreements with the Company regarding the Company’s financial, operational, accounting or repo
- Jun 18, 20268-K Regulation FD disclosure 8-K item 7.01
- May 5, 20268-K Quarterly results 8-K item 2.02
- May 5, 202610-Q Quarterly report (10-Q) period ended Mar 29, 2026
- Apr 27, 20268-K Shareholder vote results 8-K item 5.07
- Feb 26, 202610-K Annual report (10-K) period ended Dec 31, 2025
- Feb 3, 20268-K Quarterly results 8-K item 2.02
- Dec 16, 20258-K Regulation FD disclosure 8-K item 7.01
- Nov 21, 20258-K Other events 8-K item 8.01
- Nov 13, 20258-K Other events 8-K item 8.01
- Nov 4, 20258-K Quarterly results 8-K item 2.02
- Nov 4, 202510-Q Quarterly report (10-Q) period ended Sep 28, 2025
- Aug 5, 20258-K Quarterly results 8-K item 2.02
- Aug 5, 202510-Q Quarterly report (10-Q) period ended Jun 29, 2025
- May 19, 20258-K Other events 8-K item 8.01
- May 5, 202510-Q Quarterly report (10-Q) period ended Mar 30, 2025
- Apr 29, 20258-K Quarterly results, Restructuring or exit costs 8-K items 2.02, 2.05
- Apr 28, 20258-K Shareholder vote results 8-K item 5.07
- Feb 27, 202510-K Annual report (10-K) period ended Dec 31, 2024
- Feb 4, 20258-K Quarterly results 8-K item 2.02
- Dec 17, 20248-K Regulation FD disclosure 8-K item 7.01
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind
All 1001
Annual & quarterly 24Current reports (8-K) 62Insiders 740Proxy & votes 42Big owners (13D/13G) 71Shares & debt offered 18SEC letters 6Other 38
| Filed | Form | What it is | Period | |
|---|---|---|---|---|
| Mar 12, 2026 | DEFA14A | Extra proxy material | all files | |
| Mar 12, 2026 | DEF 14A | Proxy statement | Apr 23, 2026 | all files |
| Apr 11, 2025 | DEFA14A | Extra proxy material | all files | |
| Apr 10, 2025 | DEFA14A | Extra proxy material | all files | |
| Apr 10, 2025 | DEFA14A | Extra proxy material | all files | |
| Apr 10, 2025 | DEFA14A | Extra proxy material | all files | |
| Apr 7, 2025 | DEFA14A | Extra proxy material | all files | |
| Mar 25, 2025 | PX14A6G | Shareholder's proxy letter | all files | |
| Mar 13, 2025 | DEFA14A | Extra proxy material | all files | |
| Mar 13, 2025 | DEF 14A | Proxy statement | Apr 24, 2025 | all files |
| Apr 16, 2024 | PX14A6G | Shareholder's proxy letter | all files | |
| Apr 11, 2024 | DEFA14A | Extra proxy material | all files | |
| Apr 11, 2024 | DEFA14A | Extra proxy material | all files | |
| Apr 11, 2024 | DEFA14A | Extra proxy material | all files | |
| Apr 9, 2024 | DEFA14A | Extra proxy material | all files | |
| Mar 28, 2024 | DEFA14A | Extra proxy material | all files | |
| Mar 28, 2024 | DEFA14A | Extra proxy material | all files | |
| Mar 14, 2024 | DEFA14A | Extra proxy material | all files | |
| Mar 14, 2024 | DEF 14A | Proxy statement | Apr 25, 2024 | all files |
| Apr 12, 2023 | PX14A6G | Shareholder's proxy letter | all files | |
| Apr 10, 2023 | DEFA14A | Extra proxy material | all files | |
| Apr 10, 2023 | DEFA14A | Extra proxy material | all files | |
| Apr 4, 2023 | PX14A6G | Shareholder's proxy letter | all files | |
| Mar 30, 2023 | DEFA14A | Extra proxy material | all files | |
| Mar 22, 2023 | PX14A6G | Shareholder's proxy letter | all files | |
| Mar 16, 2023 | DEFA14A | Extra proxy material | all files | |
| Mar 16, 2023 | DEF 14A | Proxy statement | all files | |
| Apr 22, 2022 | DEFA14A | Extra proxy material | all files | |
| Apr 14, 2022 | PX14A6G | Shareholder's proxy letter | all files | |
| Apr 11, 2022 | DEFA14A | Extra proxy material | all files | |
| Apr 6, 2022 | DEFA14A | Extra proxy material | all files | |
| Mar 30, 2022 | DEFA14A | Extra proxy material | all files | |
| Mar 21, 2022 | PX14A6G | Shareholder's proxy letter | all files | |
| Mar 21, 2022 | PX14A6G | Shareholder's proxy letter | all files | |
| Mar 17, 2022 | DEFA14A | Extra proxy material | all files | |
| Mar 17, 2022 | DEF 14A | Proxy statement | Apr 28, 2022 | all files |
| Apr 15, 2021 | DEFA14A | Extra proxy material | all files | |
| Mar 29, 2021 | DEFA14A | Extra proxy material | all files | |
| Mar 23, 2021 | PX14A6G | Shareholder's proxy letter | all files | |
| Mar 22, 2021 | PX14A6G | Shareholder's proxy letter | all files | |
| Mar 12, 2021 | DEFA14A | Extra proxy material | all files | |
| Mar 12, 2021 | DEF 14A | Proxy statement | Apr 22, 2021 | all files |
Show the other 17 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.